Comparison of the use of remifentanil in infusion and patient-controlled methods for sedation purposes
Eurasian Journal of Anesthesiology and Intensive Care · 2024
DOI: 10.51271/eajaic-0012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Eurasian Journal of Anesthesiology and Intensive Care, 2024. Verfasst von Oya Kale und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
In this study, the infusion and patient-controlled with PCA device use of remifentanil used for sedation were compared in patients who were planned to undergo spermatic vein ligation under local anesthesia.
Methods
Thirty patient between the ages of 15-45 who were in the ASA I-II group were included in the study. They were randomly divided into 3 groups: continuous infusion (Group I), patient-controlled sedation (Group P) and control group (Group C). All patients were premedicated with 0.07 mg/kg midazolam intravenously (IV). 0.1 µg/kg/min remifentanil was given to Group I, 0.5 µg/kg bolus remifentanil was given to Group P, and physiological saline was given to Group C via a PCA (patient-controlled analgesia) device. The patients' hemodynamic parameters, sedation levels, anxiety scores, drug consumption amounts, patient satisfaction and side effects were recorded in the intraoperative and postoperative periods. During the operation, 2-3 L/min oxygen was administered via mask to patients whose SpO2 fell below 93%.
Results
Respiratory depression was more common in Group I but respiratory rate did not fall below 8 in any group. In Group I, 7 patient, in Group P, 4 patient required intraoperative oxygen. The total amount of drug consumed was 64.4 µg in Group P and 147.5 µg in Group I. Although the number of PCA requests was not different, 4 patients in Group I, 2 patients in Group P and 1 patient in Group C never pressed the device. In terms of patient satisfaction, 30% of the patients in Group I said it was excellent, while in Group C it was not evaluated as perfect. The number of patients who evaluated the method as excellent and very good was higher in Group P than Group I.
Conclusion
Remifentanil sedation with a PCA device can be used safely compared to infusion in patients undergoing spermatic vein ligation under local anesthesia.
Zitieren
APA
Kale, O., Ergil, J., & Gümüş, İ. H. (2024). Comparison of the use of remifentanil in infusion and patient-controlled methods for sedation purposes. Eurasian Journal of Anesthesiology and Intensive Care. https://doi.org/10.51271/eajaic-0012
Vancouver
Kale O, Ergil J, Gümüş İH. Comparison of the use of remifentanil in infusion and patient-controlled methods for sedation purposes. Eurasian Journal of Anesthesiology and Intensive Care. 2024. doi:10.51271/eajaic-0012
BibTeX
@article{Kale2024,
author = {Kale, Oya and Ergil, Jülide and Gümüş, İbrahim Haluk},
title = {Comparison of the use of remifentanil in infusion and patient-controlled methods for sedation purposes},
journal = {Eurasian Journal of Anesthesiology and Intensive Care},
year = {2024},
doi = {10.51271/eajaic-0012}
}
EUVIMED